Drug information: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Category:Binding Working Group]] | |||
Return to [[Main_Page|GOC Main Page]] | Return to [[Main_Page|GOC Main Page]] | ||
Latest revision as of 12:53, 23 April 2014
Return to GOC Main Page
Return to Binding terms working group page
Should we capture drug information? often artifical substrates. Also Rex raised RGD binding as an example of an artificial substrate.